Header Leaderboard Ad

Collapse

Read runs and technical replicates

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Read runs and technical replicates

    So I've downloaded some example data from SRA archives at http://www.ncbi.nlm.nih.gov/sra?term=SRA011001 and had a question about technical and biological replicates (see attached picture for a snapshot of the downloads). I know that there are two biological replicates for control and treatment conditions (in this case a miR155 over-expression retrovirus) but I'm not sure about the technical replicates.

    Do read runs count as technical replicates?

    And, if so, how can I use that in my analysis pipeline (currently I'm using the Tuxedo suite (i.e. tophat > cufflinks > cuffmerge, etc.)).

    Right now I think I'm just telling the program that there are six biological replicates of each condition (i.e. 6 x miR155oe vs. 6 x control) which is probably wrong.

    Thanks, Scott
    Attached Files

  • #2
    It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.

    Comment


    • #3
      Originally posted by chadn737 View Post
      It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.
      Is there paper where this is shown?

      So perhaps I should merge my .sam files per biological replicate and then do the tophat/bowtie alignment?

      Thanks.

      Comment


      • #4
        Marioni, J. C., C. E. Mason, S. M. Mane, M. Stephens and Y. Gilad,
        2008 RNA-Seq: an assessment of technical reproducibility and
        comparison with gene expression arrays. Genome Res. 18: 1509–1517.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          How RNA-Seq is Transforming Cancer Studies
          by seqadmin



          Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...
          09-07-2023, 11:15 PM
        • seqadmin
          Methods for Investigating the Transcriptome
          by seqadmin




          Ribonucleic acid (RNA) represents a range of diverse molecules that play a crucial role in many cellular processes. From serving as a protein template to regulating genes, the complex processes involving RNA make it a focal point of study for many scientists. This article will spotlight various methods scientists have developed to investigate different RNA subtypes and the broader transcriptome.

          Whole Transcriptome RNA-seq
          Whole transcriptome sequencing...
          08-31-2023, 11:07 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 09-22-2023, 09:05 AM
        0 responses
        14 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-21-2023, 06:18 AM
        0 responses
        12 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-20-2023, 09:17 AM
        0 responses
        13 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-19-2023, 09:23 AM
        0 responses
        28 views
        0 likes
        Last Post seqadmin  
        Working...
        X